Alliance Wealth Advisors LLC UT Buys 416 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Alliance Wealth Advisors LLC UT increased its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 3.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,262 shares of the medical device company’s stock after buying an additional 416 shares during the quarter. Alliance Wealth Advisors LLC UT’s holdings in Cooper Companies were worth $1,035,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of COO. Victory Capital Management Inc. increased its position in shares of Cooper Companies by 23.0% during the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after purchasing an additional 737,726 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Cooper Companies by 13.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after acquiring an additional 573,908 shares in the last quarter. International Assets Investment Management LLC bought a new stake in Cooper Companies during the 3rd quarter worth approximately $46,727,000. Swedbank AB raised its position in Cooper Companies by 14.0% in the 4th quarter. Swedbank AB now owns 1,629,602 shares of the medical device company’s stock valued at $149,809,000 after purchasing an additional 200,000 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Cooper Companies by 11.9% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock worth $200,665,000 after purchasing an additional 194,118 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Down 1.3 %

Shares of NASDAQ COO opened at $95.34 on Tuesday. The firm’s fifty day moving average is $95.65 and its 200 day moving average is $99.74. The Cooper Companies, Inc. has a 52 week low of $84.76 and a 52 week high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The company has a market cap of $19.03 billion, a price-to-earnings ratio of 48.89, a PEG ratio of 2.45 and a beta of 0.99.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter last year, the business posted $0.87 EPS. The firm’s revenue for the quarter was up 9.8% compared to the same quarter last year. On average, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Ratings Changes

COO has been the topic of a number of research analyst reports. Morgan Stanley decreased their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Citigroup reduced their price objective on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a report on Friday, December 6th. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. Finally, Wells Fargo & Company raised their price target on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Four analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.